QY Research, Inc.

Pulmonary Function Testing Systems Market Is Expected to Reach 470 Million US$ by 2025 – QY Research

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.


City of Industry, CA -- (SBWIRE) -- 08/01/2018 -- This report studies the global Pulmonary Function Testing Systems market status and forecast, categorizes the global Pulmonary Function Testing Systems market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Europe's sales volume accounted for the highest market share (28.23%) in 2016, followed by the North America and China.

At present, the manufactures of Pulmonary Function Testing Systems are concentrated in North America, Europe, China and Japan. Europe is the largest production area in the world, which occupied about 31.42% production share in 2016. The global leading players in this market are CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD MGC Diagnostics, etc.

The Pulmonary Function Testing Systems are mainly used by Hospitals, Physical Examination Center and Physician Groups. The dominant application of Pulmonary Function Testing Systems is Hospitals.

In the last few years, the total number of high-tech Pulmonary Function Testing Systems developed by domestic manufacturers is limited. This shows that the efforts to develop high-tech product in China is not enough, but also shows that the allocation space of domestic Pulmonary Function Testing Systems still need to expand. There is still a big gap compared with the imported Pulmonary Function Testing Systems.

Despite the presence of competition problems, as large demand of high-tech products at home and abroad, many companies began to enter the field of high-tech, emergence of technological advancements, investors are still optimistic about this area, the future will still have more new investment enter the field. But it is suggested that enterprises those have plans to enter this industry have careful analysis of this market and the advantages or disadvantages of themselves.

The global Pulmonary Function Testing Systems market is valued at 340 million US$ in 2017 and will reach 470 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2018-2025.

The major manufacturers covered in this report





nSpire Health


MGC Diagnostics




Morgan Scientific




Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America





Southeast Asia

Other regions (Central & South America, Middle East & Africa)

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/71625/global-pulmonary-function-testing-systems-market

About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.